This inventor holds 1 USPTO granted patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Carl-Magnus A Anderson
Introduction
Carl-Magnus A Anderson is a notable inventor based in Glostrup, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of muscarinic agonists. His work focuses on compounds and methods that provide treatment for various disease conditions by modifying cholinergic receptor activity.
Latest Patents
Anderson holds 1 patent related to muscarinic agonists. This patent outlines compounds and methods for treating conditions where the modulation of muscarinic m1, m4, or both receptor activities can yield beneficial effects. The method involves administering an effective amount of a compound to patients in need of such treatment.
Career Highlights
Throughout his career, Anderson has been associated with Acadia Pharmaceuticals Inc., where he has contributed to innovative research and development in the pharmaceutical industry. His expertise in cholinergic systems has positioned him as a valuable asset in the quest for new therapeutic solutions.
Collaborations
Anderson has collaborated with esteemed colleagues such as Bo Lennart M Friberg and Niels Skjaerbaek. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
Carl-Magnus A Anderson's work exemplifies the impact of innovative research in pharmacology. His contributions to muscarinic agonists highlight the importance of targeted therapies in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile